1. Home
  2. VRDN vs RLJ Comparison

VRDN vs RLJ Comparison

Compare VRDN & RLJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRDN
  • RLJ
  • Stock Information
  • Founded
  • VRDN 2006
  • RLJ 2011
  • Country
  • VRDN United States
  • RLJ United States
  • Employees
  • VRDN N/A
  • RLJ N/A
  • Industry
  • VRDN Medical Specialities
  • RLJ Real Estate Investment Trusts
  • Sector
  • VRDN Health Care
  • RLJ Real Estate
  • Exchange
  • VRDN Nasdaq
  • RLJ Nasdaq
  • Market Cap
  • VRDN 1.3B
  • RLJ 1.1B
  • IPO Year
  • VRDN N/A
  • RLJ 2011
  • Fundamental
  • Price
  • VRDN $14.34
  • RLJ $7.50
  • Analyst Decision
  • VRDN Strong Buy
  • RLJ Hold
  • Analyst Count
  • VRDN 11
  • RLJ 7
  • Target Price
  • VRDN $38.50
  • RLJ $9.96
  • AVG Volume (30 Days)
  • VRDN 750.1K
  • RLJ 1.7M
  • Earning Date
  • VRDN 08-07-2025
  • RLJ 08-07-2025
  • Dividend Yield
  • VRDN N/A
  • RLJ 7.97%
  • EPS Growth
  • VRDN N/A
  • RLJ N/A
  • EPS
  • VRDN N/A
  • RLJ 0.26
  • Revenue
  • VRDN $302,000.00
  • RLJ $1,373,555,000.00
  • Revenue This Year
  • VRDN N/A
  • RLJ $0.81
  • Revenue Next Year
  • VRDN $17,102.33
  • RLJ $1.52
  • P/E Ratio
  • VRDN N/A
  • RLJ $28.80
  • Revenue Growth
  • VRDN 4.86
  • RLJ 2.82
  • 52 Week Low
  • VRDN $9.90
  • RLJ $6.16
  • 52 Week High
  • VRDN $27.20
  • RLJ $10.84
  • Technical
  • Relative Strength Index (RSI)
  • VRDN 50.32
  • RLJ 56.97
  • Support Level
  • VRDN $14.11
  • RLJ $7.11
  • Resistance Level
  • VRDN $16.05
  • RLJ $7.54
  • Average True Range (ATR)
  • VRDN 0.74
  • RLJ 0.18
  • MACD
  • VRDN -0.13
  • RLJ 0.03
  • Stochastic Oscillator
  • VRDN 20.18
  • RLJ 78.47

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

About RLJ RLJ Lodging Trust of Beneficial Interest $0.01 par value

RLJ Lodging Trust is a real estate investment trust focused on premium-branded, rooms-oriented, high-margin, focused-service, and compact full-service hotels located within the heart of demand locations. Its hotels are geographically diverse and concentrated in urban markets providing multiple demand generators from business, leisure, and other travelers. Its hotels are under the Marriott, Hilton, and Hyatt brand names. The Hotel is a single reportable segment. Its hotel segment revenues are derived from the operation of hotel properties which includes room revenue by renting hotel rooms, food and beverage revenue from the sale of food and beverages, and other revenue from parking fees, resort fees, gift shop sales, and other guest service fees.

Share on Social Networks: